BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Badreddine RJ, Prasad GA, Lewis JT, Lutzke LS, Borkenhagen LS, Dunagan KT, Wang KK. Depth of submucosal invasion does not predict lymph node metastasis and survival of patients with esophageal carcinoma. Clin Gastroenterol Hepatol. 2010;8:248-253. [PMID: 19948247 DOI: 10.1016/j.cgh.2009.11.016] [Cited by in Crossref: 66] [Cited by in F6Publishing: 57] [Article Influence: 5.1] [Reference Citation Analysis]
Number Citing Articles
1 Rubenstein JH, Shaheen NJ. Epidemiology, Diagnosis, and Management of Esophageal Adenocarcinoma. Gastroenterology. 2015;149:302-17.e1. [PMID: 25957861 DOI: 10.1053/j.gastro.2015.04.053] [Cited by in Crossref: 182] [Cited by in F6Publishing: 175] [Article Influence: 26.0] [Reference Citation Analysis]
2 Weksler B, Kennedy KF, Sullivan JL. Using the National Cancer Database to create a scoring system that identifies patients with early-stage esophageal cancer at risk for nodal metastases. J Thorac Cardiovasc Surg. 2017;154:1787-1793. [PMID: 28867381 DOI: 10.1016/j.jtcvs.2017.07.036] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.8] [Reference Citation Analysis]
3 Aranda-Hernandez J, Cirocco M, Marcon N. Treatment of dysplasia in barrett esophagus. Clin Endosc 2014;47:55-64. [PMID: 24570884 DOI: 10.5946/ce.2014.47.1.55] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
4 Manner H, Pech O, Heldmann Y, May A, Pauthner M, Lorenz D, Fisseler-Eckhoff A, Stolte M, Vieth M, Ell C. The frequency of lymph node metastasis in early-stage adenocarcinoma of the esophagus with incipient submucosal invasion (pT1b sm1) depending on histological risk patterns. Surg Endosc. 2015;29:1888-1896. [PMID: 25294553 DOI: 10.1007/s00464-014-3881-3] [Cited by in Crossref: 54] [Cited by in F6Publishing: 49] [Article Influence: 6.8] [Reference Citation Analysis]
5 Manner H, Wetzka J, May A, Pauthner M, Pech O, Fisseler-Eckhoff A, Stolte M, Vieth M, Lorenz D, Ell C. Early-stage adenocarcinoma of the esophagus with mid to deep submucosal invasion (pT1b sm2-3): the frequency of lymph-node metastasis depends on macroscopic and histological risk patterns. Dis Esophagus. 2017;30:1-11. [PMID: 26952572 DOI: 10.1111/dote.12462] [Cited by in Crossref: 6] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
6 Bedi AO, Kwon RS, Rubenstein JH, Piraka CR, Elta GH, Scheiman JM, Elmunzer BJ. A survey of expert follow-up practices after successful endoscopic eradication therapy for Barrett’s esophagus with high-grade dysplasia and intramucosal adenocarcinoma. Gastrointest Endosc. 2013;78:696-701. [PMID: 23711553 DOI: 10.1016/j.gie.2013.04.196] [Cited by in Crossref: 13] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
7 Shaheen NJ, Falk GW, Iyer PG, Gerson LB; American College of Gastroenterology. ACG Clinical Guideline: Diagnosis and Management of Barrett's Esophagus. Am J Gastroenterol. 2016;111:30-50; quiz 51. [PMID: 26526079 DOI: 10.1038/ajg.2015.322] [Cited by in Crossref: 793] [Cited by in F6Publishing: 630] [Article Influence: 113.3] [Reference Citation Analysis]
8 Kahn A, Kamboj AK, Muppa P, Sawas T, Lutzke LS, Buras MR, Golafshar MA, Katzka DA, Iyer PG, Smyrk TC, Wang KK, Leggett CL. Staging of T1 esophageal adenocarcinoma with volumetric laser endomicroscopy: a feasibility study.Endosc Int Open. 2019;7:E462-E470. [PMID: 30931378 DOI: 10.1055/a-0838-5326] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Zeki SS, Bergman JJ, Dunn JM. Endoscopic management of dysplasia and early oesophageal cancer. Best Pract Res Clin Gastroenterol 2018;36-37:27-36. [PMID: 30551853 DOI: 10.1016/j.bpg.2018.11.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Pech O, Alqahtani SA. Update on endoscopic treatment of Barrett's oesophagus and Barrett's oesophagus-related neoplasia. Ther Adv Gastrointest Endosc 2020;13:2631774520935241. [PMID: 32783025 DOI: 10.1177/2631774520935241] [Reference Citation Analysis]
11 Graham D, Sever N, Magee C, Waddingham W, Banks M, Sweis R, Al-Yousuf H, Mitchison M, Alzoubaidi D, Rodriguez-Justo M, Lovat L, Novelli M, Jansen M, Haidry R. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience. World J Gastroenterol 2018; 24(41): 4698-4707 [PMID: 30416317 DOI: 10.3748/wjg.v24.i41.4698] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
12 Tian J, Prasad GA, Lutzke LS, Lewis JT, Wang KK. Outcomes of T1b esophageal adenocarcinoma patients. Gastrointest Endosc. 2011;74:1201-1206. [PMID: 22000793 DOI: 10.1016/j.gie.2011.08.006] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.1] [Reference Citation Analysis]
13 Emi M, Hihara J, Hamai Y, Furukawa T, Ibuki Y, Okada M. Clinicopathologic Features of Submucosal Esophageal Squamous Cell Carcinoma. Ann Thorac Surg 2017;104:1858-64. [PMID: 29033014 DOI: 10.1016/j.athoracsur.2017.06.037] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
14 Rajendra S, Sharma P. Management of Barrett's oesophagus and intramucosal oesophageal cancer: a review of recent development. Therap Adv Gastroenterol. 2012;5:285-299. [PMID: 22973415 DOI: 10.1177/1756283x12446668] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
15 Merkow RP, Bilimoria KY, Keswani RN, Chung J, Sherman KL, Knab LM, Posner MC, Bentrem DJ. Treatment trends, risk of lymph node metastasis, and outcomes for localized esophageal cancer. J Natl Cancer Inst. 2014;106. [PMID: 25031273 DOI: 10.1093/jnci/dju133] [Cited by in Crossref: 71] [Cited by in F6Publishing: 77] [Article Influence: 8.9] [Reference Citation Analysis]
16 Boys JA, Worrell SG, Chandrasoma P, Vallone JG, Maru DM, Zhang L, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study. J Gastrointest Surg. 2016;20:6-12; discussion 12. [PMID: 26408330 DOI: 10.1007/s11605-015-2950-9] [Cited by in Crossref: 43] [Cited by in F6Publishing: 39] [Article Influence: 6.1] [Reference Citation Analysis]
17 Mitchell DP, Yeluri S, Van der Wall H, Falk GL. The real risk of nodal disease in T1 oesophageal adenocarcinoma: A systematic review. Eur Surg 2020;52:110-7. [DOI: 10.1007/s10353-019-00627-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Fotis D, Doukas M, Wijnhoven BP, Didden P, Biermann K, Bruno MJ, Koch AD. Submucosal invasion and risk of lymph node invasion in early Barrett's cancer: potential impact of different classification systems on patient management. United European Gastroenterol J 2015;3:505-13. [PMID: 26668743 DOI: 10.1177/2050640615581965] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
19 Qi X, Li M, Zhao S, Luo J, Shao Y, Zhang Z, Chen Y. Prevalence of metastasis in T1b esophageal squamous cell carcinoma: a retrospective analysis of 258 Chinese patients. J Thorac Dis 2016;8:966-76. [PMID: 27162673 DOI: 10.21037/jtd.2016.03.69] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
20 Pech O, Manner H, Ell C. Endoscopic resection. Gastrointest Endosc Clin N Am 2011;21:81-94. [PMID: 21112499 DOI: 10.1016/j.giec.2010.10.001] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 1.7] [Reference Citation Analysis]
21 Jiang D, Li X, Wang H, Xu C, Li X, Sujie A, Zeng H, Hou Y, Zhong Y. A retrospective study of endoscopic resection for 368 patients with early esophageal squamous cell carcinoma or precancerous lesions. Surg Endosc 2017;31:2122-30. [PMID: 27837320 DOI: 10.1007/s00464-016-5208-z] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
22 Wang S, Huang Y, Xie J, Zhuge L, Shao L, Xiang J, Zhang Y, Sun Y, Hu H, Chen S, Lerut T, Luketich JD, Zhang J, Chen H. Does delayed esophagectomy after endoscopic resection affect outcomes in patients with stage T1 esophageal cancer? Surg Endosc. 2018;32:1441-1448. [PMID: 28916920 DOI: 10.1007/s00464-017-5830-4] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
23 Wani S, Abrams J, Edmundowicz SA, Gaddam S, Hovis CE, Green D, Gupta N, Higbee A, Bansal A, Rastogi A, Early D, Lightdale CJ, Sharma P. Endoscopic mucosal resection results in change of histologic diagnosis in Barrett's esophagus patients with visible and flat neoplasia: a multicenter cohort study. Dig Dis Sci 2013;58:1703-9. [PMID: 23633158 DOI: 10.1007/s10620-013-2689-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 42] [Article Influence: 5.8] [Reference Citation Analysis]
24 Yin F, Hernandez Gonzalo D, Lai J, Liu X. Histopathology of Barrett’s Esophagus and Early-Stage Esophageal Adenocarcinoma: An Updated Review. GastrointestDisord 2018;1:147-63. [DOI: 10.3390/gidisord1010011] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Marino KA, Sullivan JL, Weksler B. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study. J Thorac Cardiovasc Surg 2018;155:2211-2218.e1. [PMID: 29455958 DOI: 10.1016/j.jtcvs.2017.11.111] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 4.3] [Reference Citation Analysis]
26 Liu JY, Liu BR. Minimally invasive treatments for Barrett's esophagus. Shijie Huaren Xiaohua Zazhi 2012; 20(36): 3707-3712 [DOI: 10.11569/wcjd.v20.i36.3707] [Reference Citation Analysis]
27 Namasivayam V, Wang KK, Prasad GA. Endoscopic mucosal resection in the management of esophageal neoplasia: current status and future directions. Clin Gastroenterol Hepatol. 2010;8:743-54; quiz e96. [PMID: 20541628 DOI: 10.1016/j.cgh.2010.05.030] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 2.3] [Reference Citation Analysis]
28 Repaka A, Chak A. Endoscopic management of Barrett esophagus. Nat Rev Gastroenterol Hepatol 2011;8:582-91. [DOI: 10.1038/nrgastro.2011.151] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
29 Pech O, Ell C. Frühes Ösophaguskarzinom: Pro endoskopische Resektion. Chirurg 2011;82:490-4. [DOI: 10.1007/s00104-010-2059-3] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
30 Otaki F, Ma GK, Krigel A, Dierkhising RA, Lewis JT, Blevins CH, Gopalakrishnan NP, Ravindran A, Johnson ML, Leggett CL, Wigle D, Wang KK, Falk GW, Abrams JA, Nakagawa H, Rustgi AK, Wang TC, Lightdale CJ, Ginsberg GG, Iyer PG. Outcomes of patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Gastrointest Endosc 2020;92:31-39.e1. [PMID: 31953189 DOI: 10.1016/j.gie.2020.01.013] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
31 Bollschweiler E, Hölscher AH. Early adenocarcinoma of the esophagus - clinical relevance of depth of infiltration into the submucosa. Clin Gastroenterol Hepatol 2011;9:277; author reply 277-8. [PMID: 20951839 DOI: 10.1016/j.cgh.2010.10.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Manner H, Pech O, Ell C. Barrett's: evolving techniques for dysplasia detection and endoscopic resection. Semin Thorac Cardiovasc Surg 2010;22:321-9. [PMID: 21549272 DOI: 10.1053/j.semtcvs.2011.01.008] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
33 Bartel MJ, Wallace TM, Gomez-Esquivel RD, Raimondo M, Wolfsen HC, Woodward TA, Wallace MB. Role of EUS in patients with suspected Barrett's esophagus with high-grade dysplasia or early esophageal adenocarcinoma: impact on endoscopic therapy. Gastrointest Endosc. 2017;86:292-298. [PMID: 27889544 DOI: 10.1016/j.gie.2016.11.016] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
34 Max Almond L, Barr H. Management controversies in Barrett’s oesophagus. J Gastroenterol. 2013;Jun 5; Epub ahead of print. [PMID: 23736794 DOI: 10.1007/s00535-013-0816-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
35 Ballard DD, Choksi N, Lin J, Choi EY, Elmunzer BJ, Appelman H, Rex DK, Fatima H, Kessler W, DeWitt JM. Outcomes of submucosal (T1b) esophageal adenocarcinomas removed by endoscopic mucosal resection. World J Gastrointest Endosc 2016; 8(20): 763-769 [PMID: 28042390 DOI: 10.4253/wjge.v8.i20.763] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
36 Molena D, Schlottmann F, Boys JA, Blackmon SH, Dickinson KJ, Dunst CM, Hofstetter WL, Lada MJ, Louie BE, Mungo B, Watson TJ, DeMeester SR. Esophagectomy Following Endoscopic Resection of Submucosal Esophageal Cancer: a Highly Curative Procedure Even with Nodal Metastases. J Gastrointest Surg 2017;21:62-7. [PMID: 27561633 DOI: 10.1007/s11605-016-3210-3] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
37 Davison JM, Landau MS, Luketich JD, McGrath KM, Foxwell TJ, Landsittel DP, Gibson MK, Nason KS. A Model Based on Pathologic Features of Superficial Esophageal Adenocarcinoma Complements Clinical Node Staging in Determining Risk of Metastasis to Lymph Nodes. Clin Gastroenterol Hepatol 2016;14:369-377.e3. [PMID: 26515637 DOI: 10.1016/j.cgh.2015.10.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
38 Landau MS, Hastings SM, Foxwell TJ, Luketich JD, Nason KS, Davison JM. Tumor budding is associated with an increased risk of lymph node metastasis and poor prognosis in superficial esophageal adenocarcinoma. Mod Pathol 2014;27:1578-89. [PMID: 24762549 DOI: 10.1038/modpathol.2014.66] [Cited by in Crossref: 30] [Cited by in F6Publishing: 30] [Article Influence: 3.8] [Reference Citation Analysis]
39 Manner H, Pech O, Heldmann Y, May A, Pohl J, Behrens A, Gossner L, Stolte M, Vieth M, Ell C. Efficacy, safety, and long-term results of endoscopic treatment for early stage adenocarcinoma of the esophagus with low-risk sm1 invasion. Clin Gastroenterol Hepatol. 2013;11:630-5; quiz e45. [PMID: 23357492 DOI: 10.1016/j.cgh.2012.12.040] [Cited by in Crossref: 139] [Cited by in F6Publishing: 111] [Article Influence: 15.4] [Reference Citation Analysis]
40 Rajendra S, Sharma P. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma. Hematol Oncol Clin North Am 2017;31:409-26. [PMID: 28501084 DOI: 10.1016/j.hoc.2017.01.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
41 Hölscher AH, Bollschweiler E, Schröder W, Metzger R, Gutschow C, Drebber U. Prognostic impact of upper, middle, and lower third mucosal or submucosal infiltration in early esophageal cancer. Ann Surg. 2011;254:802-807; discussion 807-808. [PMID: 22042472 DOI: 10.1097/sla.0b013e3182369128] [Cited by in Crossref: 84] [Cited by in F6Publishing: 33] [Article Influence: 8.4] [Reference Citation Analysis]
42 Ayers K, Shi C, Washington K, Yachimski P. Expert pathology review and endoscopic mucosal resection alters the diagnosis of patients referred to undergo therapy for Barrett's esophagus. Surg Endosc 2013;27:2836-40. [PMID: 23389078 DOI: 10.1007/s00464-013-2830-x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.2] [Reference Citation Analysis]
43 Dent J. Barrett's esophagus: A historical perspective, an update on core practicalities and predictions on future evolutions of management. J Gastroenterol Hepatol 2011;26 Suppl 1:11-30. [PMID: 21199510 DOI: 10.1111/j.1440-1746.2010.06535.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 29] [Article Influence: 3.6] [Reference Citation Analysis]
44 Rajendra S, Sharma P. Barrett's Esophagus. Curr Treat Options Gastroenterol 2014;12:169-82. [PMID: 24634008 DOI: 10.1007/s11938-014-0012-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
45 Hölscher AH, Bollschweiler E. Frequency of lymph node metastasis in submucosal esophageal cancer. Ann Surg 2014;259:e84. [PMID: 24169170 DOI: 10.1097/SLA.0000000000000298] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
46 Falk GW. Update on ablation for Barrett's esophagus. Curr Gastroenterol Rep 2014;16:368. [PMID: 24357349 DOI: 10.1007/s11894-013-0368-7] [Reference Citation Analysis]
47 Fernández-Sordo JO, Konda VJ, Chennat J, Madrigal-Hoyos E, Posner MC, Ferguson MK, Waxman I. Is Endoscopic Ultrasound (EUS) necessary in the pre-therapeutic assessment of Barrett's esophagus with early neoplasia? J Gastrointest Oncol 2012;3:314-21. [PMID: 23205307 DOI: 10.3978/j.issn.2078-6891.2012.038] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
48 Pech O, Bollschweiler E, Manner H, Leers J, Ell C, Hölscher AH. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg. 2011;254:67-72. [PMID: 21532466 DOI: 10.1097/sla.0b013e31821d4bf6] [Cited by in Crossref: 189] [Cited by in F6Publishing: 69] [Article Influence: 17.2] [Reference Citation Analysis]
49 Manner H, Pech O. Measurement of the tumor invasion depth into the submucosa in early adenocarcinoma of the esophagus (pT1b): Can microns be the new standard for the endoscopist? United European Gastroenterol J 2015;3:501-4. [PMID: 26668742 DOI: 10.1177/2050640615617724] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
50 Wang X, Cao Y, Zhang S, Chen Z, Fan L, Shen X, Zhou S, Chen D. Stem cell autocrine CXCL12/CXCR4 stimulates invasion and metastasis of esophageal cancer. Oncotarget 2017;8:36149-60. [PMID: 28193907 DOI: 10.18632/oncotarget.15254] [Cited by in Crossref: 23] [Cited by in F6Publishing: 24] [Article Influence: 5.8] [Reference Citation Analysis]
51 Wani S, Early D, Edmundowicz S, Sharma P. Management of high-grade dysplasia and intramucosal adenocarcinoma in Barrett's esophagus. Clin Gastroenterol Hepatol 2012;10:704-11. [PMID: 22507878 DOI: 10.1016/j.cgh.2012.03.030] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.0] [Reference Citation Analysis]
52 Rocha-Filho DR, Peixoto RD, Weschenfelder RF, Rego JFM, Riechelmann R, Coutinho AK, Fernandes GS, Jacome AA, Andrade AC, Murad AM, Mello CAL, Miguel DSCG, Gomes DBD, Racy DJ, Moraes ED, Akaishi EH, Carvalho ES, Mello ES, Filho FM, Coimbra FJF, Capareli FC, Arruda FF, Vieira FMAC, Takeda FR, Cotti GCC, Pereira GLS, Paulo GA, Ribeiro HSC, Lourenco LG, Crosara M, Toneto MG, Oliveira MB, de Lourdes Oliveira M, Begnami MD, Forones NM, Yagi O, Ashton-Prolla P, Aguillar PB, Amaral PCG, Hoff PM, Araujo RLC, Di Paula Filho RP, Gansl RC, Gil RA, Pfiffer TEF, Souza T, Ribeiro U Jr, Jesus VHF, Costa WL Jr, Prolla G. Brazilian Group of Gastrointestinal Tumours' consensus guidelines for the management of oesophageal cancer. Ecancermedicalscience 2021;15:1195. [PMID: 33889204 DOI: 10.3332/ecancer.2021.1195] [Reference Citation Analysis]
53 Benech N, O'Brien JM, Barret M, Jacques J, Rahmi G, Perrod G, Hervieu V, Jaouen A, Charissoux A, Guillaud O, Legros R, Walter T, Saurin JC, Rivory J, Prat F, Lépilliez V, Ponchon T, Pioche M. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases. United European Gastroenterol J 2021;9:362-9. [PMID: 32903167 DOI: 10.1177/2050640620958903] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
54 Ramay FH, Vareedayah AA, Visrodia K, Iyer PG, Wang KK, Eluri S, Shaheen NJ, Reddy R, Martin LW, Greenwald BD, Edwards MA. What Constitutes Optimal Management of T1N0 Esophageal Adenocarcinoma? Ann Surg Oncol 2019;26:714-31. [DOI: 10.1245/s10434-018-07118-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
55 Pech O. Endoscopic Treatment of Early Barrett's Neoplasia: Expanding Indications, New Challenges. Adv Exp Med Biol 2016;908:99-109. [PMID: 27573769 DOI: 10.1007/978-3-319-41388-4_6] [Reference Citation Analysis]
56 Akutsu Y, Uesato M, Shuto K, Kono T, Hoshino I, Horibe D, Sazuka T, Takeshita N, Maruyama T, Isozaki Y, Akanuma N, Matsubara H. The Overall Prevalence of Metastasis in T1 Esophageal Squamous Cell Carcinoma: A Retrospective Analysis of 295 Patients. Annals of Surgery 2013;257:1032-8. [DOI: 10.1097/sla.0b013e31827017fc] [Cited by in Crossref: 85] [Cited by in F6Publishing: 43] [Article Influence: 9.4] [Reference Citation Analysis]
57 Baretton GB, Aust DE. [Barrett's esophagus. An update]. Pathologe. 2012;33:5-16. [PMID: 22293785 DOI: 10.1007/s00292-011-1541-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
58 Lorenz D, Origer J, Pauthner M, Graupe F, Fisseler-Eckhoff A, Stolte M, Pech O, Ell C. Prognostic risk factors of early esophageal adenocarcinomas. Ann Surg. 2014;259:469-476. [PMID: 24096754 DOI: 10.1097/sla.0000000000000217] [Cited by in Crossref: 33] [Cited by in F6Publishing: 16] [Article Influence: 4.1] [Reference Citation Analysis]
59 Chennat J, Konda VJ, Waxman I. Endotherapy for Barrett's esophagus: Which, how, when, and who? Gastrointest Endosc Clin N Am 2011;21:119-33. [PMID: 21112502 DOI: 10.1016/j.giec.2010.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
60 Tomizawa Y, Wu TT, Wang KK. Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus. Oncol Lett. 2012;3:1059-1063. [PMID: 22783391 DOI: 10.3892/ol.2012.632] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.2] [Reference Citation Analysis]